<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xsi:schemaLocation="http://www.sec.gov/edgar/thirteenffiler eis_13F_Filer.xsd" xmlns:ns1="http://www.sec.gov/edgar/common" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sec.gov/edgar/thirteenffiler">
  <schemaVersion>X0202</schemaVersion>
  <headerData>
    <submissionType>13F-NT</submissionType>
    <filerInfo>
      <liveTestFlag>LIVE</liveTestFlag>
      <flags/>
      <filer>
        <credentials>
          <cik>0002015553</cik>
          <ccc>XXXXXXXX</ccc>
        </credentials>
      </filer>
      <periodOfReport>09-30-2026</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <reportCalendarOrQuarter>09-30-2026</reportCalendarOrQuarter>
      <isAmendment>false</isAmendment>
      <filingManager>
        <name>Bain Capital Life Sciences Opportunities IV, L.P.</name>
        <address>
          <ns1:street1>200 Clarendon Street </ns1:street1>
          <ns1:city>Boston</ns1:city>
          <ns1:stateOrCountry>MA</ns1:stateOrCountry>
          <ns1:zipCode>02116</ns1:zipCode>
        </address>
      </filingManager>
      <reportType>13F NOTICE</reportType>
      <form13FFileNumber>028-26575</form13FFileNumber>
      <otherManagersInfo>
        <otherManager>
          <form13FFileNumber>28-18477</form13FFileNumber>
          <name>Bain Capital Life Sciences Investors, LLC</name>
        </otherManager>
        <otherManager>
          <form13FFileNumber>28-26578</form13FFileNumber>
          <name>Bain Capital Life Sciences IV General Partner, LLC</name>
        </otherManager>
        <otherManager>
          <form13FFileNumber>28-26577</form13FFileNumber>
          <name>Bain Capital Life Sciences Fund IV, L.P.</name>
        </otherManager>
        <otherManager>
          <form13FFileNumber>28-26576</form13FFileNumber>
          <name>Bain Capital Life Sciences Opportunities IV GP, LLC</name>
        </otherManager>
      </otherManagersInfo>
      <provideInfoForInstruction>Y</provideInfoForInstruction>
      <additionalInformation>The report on Form 13F for the period ended September 30, 2026 for Bain Capital Life Sciences Opportunities IV, L.P. (the "Fund") is being filed by Bain Capital Life Sciences Investors, LLC, which is the manager of Bain Capital Life Sciences IV General Partner, LLC, which is the general partner of Bain Capital Life Sciences Fund IV, L.P., which is the sole member of Bain Capital Life Sciences Opportunities IV GP, LLC, which is the general partner of the Fund.</additionalInformation>
    </coverPage>
    <signatureBlock>
      <name>Adam Koppel</name>
      <title>Partner of Bain Capital Life Sciences Investors, LLC</title>
      <phone>617-516-2000</phone>
      <signature>/s/ Adam Koppel</signature>
      <city>Boston </city>
      <stateOrCountry>MA</stateOrCountry>
      <signatureDate>11-16-2026</signatureDate>
    </signatureBlock>
  </formData>
</edgarSubmission>
